diabetes tirzepatide Cuts Risk of by 94% in Prediabetic Adults Semaglutide and tirzepatide treatment leads

And North Carolina Medicaid announced it would no longer cover Wegovy or Zepbound except for diabetes or heart uses

Additionally, these agents may influence food reward pathways in the brain, potentially reducing cravings for high-calorie foods

Heres who might be able to use them: Adults With Higher BMI You might qualify for GLP-1 weight loss medication if: Your BMI is 30 or higher, or Your BMI is 27 or higher and you have weight-related health problems BMI (Body Mass Index) is a way to measure if your weight might affect your health

Zepbound has a similar program

Thanks Dr for your kind sharing, but tirzepatide pair provides stronger glycemic control and more weight loss either than alone, which eventually have a better impact over CV outcomes See more comments To view or add a comment, sign in More Relevant Posts 18,391 followers Diabetes and Well-being

In practice, providers who regularly work with patients on GLP-1 therapy often notice that people who make small dietary adjustments early, rather than waiting for symptoms to become uncomfortable, tend to report fewer flare-ups of this side effect over the following weeks